Plaisy M, Minga A, Wandeler G, Murenzi G, Samala N, Ross J
J Int AIDS Soc. 2024; 27(4):e26238.
PMID: 38566493
PMC: 10988113.
DOI: 10.1002/jia2.26238.
Mally A, Jarzina S
Front Toxicol. 2022; 4:863643.
PMID: 35785263
PMC: 9242087.
DOI: 10.3389/ftox.2022.863643.
Hoogstraten C, Smeitink J, Russel F, Schirris T
Front Toxicol. 2022; 4:842396.
PMID: 35295229
PMC: 8915871.
DOI: 10.3389/ftox.2022.842396.
Bryant J, Lei Y, VanPortfliet J, Winters A, Phillip West A
Curr Protoc. 2022; 2(2):e372.
PMID: 35175686
PMC: 8986093.
DOI: 10.1002/cpz1.372.
Johnson K, Dangerfield T
Enzymes. 2021; 49:39-62.
PMID: 34696838
PMC: 8474024.
DOI: 10.1016/bs.enz.2021.07.001.
Tenofovir nephrotoxicity among Asians living with HIV: review of the literature.
Nishijima T, Gatanaga H, Oka S
Glob Health Med. 2020; 1(2):88-94.
PMID: 33330761
PMC: 7731346.
DOI: 10.35772/ghm.2019.01021.
Lipodystrophies-Disorders of the Fatty Tissue.
Knebel B, Muller-Wieland D, Kotzka J
Int J Mol Sci. 2020; 21(22).
PMID: 33233602
PMC: 7699751.
DOI: 10.3390/ijms21228778.
Identifying the role of PrimPol in TDF-induced toxicity and implications of its loss of function mutation in an HIV+ patient.
Duong V, Zhou L, Martinez-Jimenez M, He L, Cosme M, Blanco L
Sci Rep. 2020; 10(1):9343.
PMID: 32518272
PMC: 7283272.
DOI: 10.1038/s41598-020-66153-z.
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B.
Madeddu G, Fiore V, Melis M, Ortu S, Mannu F, Muredda A
Sci Rep. 2020; 10(1):2014.
PMID: 32029790
PMC: 7005185.
DOI: 10.1038/s41598-020-58837-3.
Impact of pharmacological agents on mitochondrial function: a growing opportunity?.
Stoker M, Newport E, Hulit J, Phillip West A, Morten K
Biochem Soc Trans. 2019; 47(6):1757-1772.
PMID: 31696924
PMC: 6925523.
DOI: 10.1042/BST20190280.
Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy.
Kallianpur A, Gerschenson M, Hulgan T, Kaur H, Clifford D, Haas D
AIDS Res Hum Retroviruses. 2018; 34(11):942-949.
PMID: 29968489
PMC: 6421985.
DOI: 10.1089/AID.2018.0025.
Development of peptide inhibitors of HIV transmission.
Shi S, Nguyen P, Cabral H, Diez-Barroso R, Derry P, Kanahara S
Bioact Mater. 2018; 1(2):109-121.
PMID: 29744399
PMC: 5883972.
DOI: 10.1016/j.bioactmat.2016.09.004.
Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses.
Eyer L, Nencka R, De Clercq E, Seley-Radtke K, Ruzek D
Antivir Chem Chemother. 2018; 26:2040206618761299.
PMID: 29534608
PMC: 5890575.
DOI: 10.1177/2040206618761299.
In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase.
Ferla S, Netzler N, Ferla S, Veronese S, Enosi Tuipulotu D, Guccione S
Sci Rep. 2018; 8(1):4129.
PMID: 29515206
PMC: 5841303.
DOI: 10.1038/s41598-018-22303-y.
Signatures of Nucleotide Analog Incorporation by an RNA-Dependent RNA Polymerase Revealed Using High-Throughput Magnetic Tweezers.
Dulin D, Arnold J, van Laar T, Oh H, Lee C, Perkins A
Cell Rep. 2017; 21(4):1063-1076.
PMID: 29069588
PMC: 5670035.
DOI: 10.1016/j.celrep.2017.10.005.
Identification of 2'-deoxy-2'-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus.
Welch S, Scholte F, Flint M, Chatterjee P, Nichol S, Bergeron E
Antiviral Res. 2017; 147:91-99.
PMID: 29024765
PMC: 8191813.
DOI: 10.1016/j.antiviral.2017.10.008.
Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.
Jotwani V, Atta M, Estrella M
J Am Soc Nephrol. 2017; 28(11):3142-3154.
PMID: 28784698
PMC: 5661296.
DOI: 10.1681/ASN.2017040468.
Mitochondrial DNA replication: a PrimPol perspective.
Bailey L, Doherty A
Biochem Soc Trans. 2017; 45(2):513-529.
PMID: 28408491
PMC: 5390496.
DOI: 10.1042/BST20160162.
The Δ133p53 Isoform Reduces Wtp53-induced Stimulation of DNA Pol γ Activity in the Presence and Absence of D4T.
Liu K, Zang Y, Guo X, Wei F, Yin J, Pang L
Aging Dis. 2017; 8(2):228-239.
PMID: 28400988
PMC: 5362181.
DOI: 10.14336/AD.2016.0910.
Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF Inhibition.
Hardeman K, Peng C, Paudel B, Meyer C, Luong T, Tyson D
Sci Rep. 2017; 7:42604.
PMID: 28205616
PMC: 5311997.
DOI: 10.1038/srep42604.